Savill Corrine 4
4 · Cullinan Oncology, Inc. · Filed Feb 23, 2024
Insider Transaction Report
Form 4
Savill Corrine
Chief Business Officer
Transactions
- Award
Common Stock
2024-02-22+37,500→ 203,490 total - Award
Stock Option (Right to Buy)
2024-02-22+75,000→ 75,000 totalExercise: $17.54Exp: 2034-02-22→ Common Stock (75,000 underlying)
Footnotes (2)
- [F1]The shares underlying the restricted stock unit vest on an annual basis over four years.
- [F2]The shares underlying the option vest over four years, with one forty-eighth (1/48th) of the shares vesting in equal monthly installments until the fourth anniversary of the grant date.